SeeNews

Slovenia's Krka repurchases 4,822 own shares

Slovenian pharmaceuticals producer Krka raised its own shareholdings to 7.452% from 7.437% after repurchasing 4,822 of its ...
Reuters

Slovenia's Krka eyes takeover targets

LJUBLJANA, April 24 (Reuters) - Slovenian generic drug producer Krka is actively looking to expand its business and could announce a takeover later in the year, Chief Executive Joze Colaric told ...
Reuters

Slovenia's Krka net profit down by 3 pct

LJUBLJANA, Nov 15 (Reuters) - Generic drugs producer Krka, Slovenia's largest listed company, posted nine-month group net profit of 111.5 million euros ($141.9 million), down 3 percent compared with ...
FiercePharma

Baxter plans $1B plasma operation in Georgia; Slovenia's Krka on hunt for buyout;

> Baxter International ($BAX) is plotting a $1 billion plasma-processing complex in Atlanta, supported by collection facilities around the state of Georgia. Report ...
Bloomberg L.P.

Slovenia’s Krka Says Court Rules It Breached AstraZeneca Patent

Krka Group d.d., Slovenia’s biggest drug company, said an Oslo court ruled that its Swedish unit breached AstraZeneca Plc’s patent over the drug esomeprazole. The Norwegian court ruled Krka infringed ...